Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.55 |
| ▸ | PPARA | Q07869 | 2/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.49 |
| ▸ | RARB | P10826 | 3/20 | 0.47 |
| ▸ | RARA | P10276 | 1/20 | 0.47 |
| ▸ | RARG | P13631 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | BID | P55957 | 2/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.44 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9061472 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL9061041 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL51647 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL5160516 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL9061592 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL719922 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL5709508 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL221376 | 1.00 | KAT8 (0.55) | KAT8PPARAALOX5RARBRARA | |
| SCHEMBL27729778 | 0.98 | KAT8 (0.53) | KAT8PPARAALOX5RARBRARA | |
| Ethylene Glycol SCHEMBL28757868 | 0.94 | KAT8 (0.49) | KAT8PPARAALOX5RARBRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3621451-B1 | SURFACE-REACTED CALCIUM CARBONATE IN FOOD | OMYA INT AG (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4045544-B1 | SUPER ADVANCED CONTROLLED RADICAL POLYMERIZATION | BASF COATINGS GMBH (DE) | 2026-03-18 | — | — | EP | claimed |
| EP-4531810-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | Boehringer Ingelheim Vetmedica GmbH (DE) | 2025-04-09 | — | — | EP | claimed |
| EP-3042645-B2 | Dental composites with improved storage stability | IVOCLAR VIVADENT AG (LI) | 2025-03-12 | — | — | EP | claimed |
| EP-3227360-B1 | ANTIOXIDANT-INFUSED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE | ZIMMER INC (US) | 2024-10-16 | — | — | EP | claimed |
| WO-2023227492-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2023-11-30 | — | — | WO | claimed |
| US-20230381101-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2023-11-30 | — | — | US | claimed |
| EP-3589426-B1 | FURNITURE LUBRICANT COMPRISING A C10 TO C28 ALKANE AND A TRI-GLYCERIDE | IKEA SUPPLY AG (CH) | 2023-07-12 | — | — | EP | claimed |
| EP-2381797-B2 | ANIMAL FEED ADDITIVE AND ANIMAL FEED COMPRISING ALKYL ESTERS OF MEDIUM CHAIN FATTY ACIDS, AND THEIR USE IN ANIMAL FEED | NUTRECO NEDERLAND BV (NL) | 2023-05-31 | — | — | EP | claimed |
| EP-3485870-B1 | STABILISING COSMETIC COMPOSITION FOR REDUCING THE DEGRADATION OF UNSTABLE COSMETIC ACTIVE INGREDIENTS | THOREL JEAN NOEL (FR) | 2023-03-08 | — | — | EP | claimed |
| US-20060019840-A1 | Lubricating oil for bearing | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2006-01-26 | — | — | US | claimed |
| WO-2006002777-A1 | BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2006-01-12 | — | — | WO | claimed |
| WO-2006002714-A1 | CARE COMPOSITION | UNILEVER PLC (GB) | 2006-01-12 | — | — | WO | claimed |
| WO-2005118764-A1 | BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2005-12-15 | — | — | WO | claimed |
| WO-2005118763-A1 | BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2005-12-15 | — | — | WO | claimed |
| US-20040058983-A1 | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections | CONTROL-OX OY (FI) | 2004-03-25 | — | — | US | claimed |
| JP-2004506656-A | — | — | 2004-03-04 | — | — | JP | claimed |
| EP-1309333-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | Control-Ox OY (FI) | 2003-05-14 | — | — | EP | claimed |
| WO-2002014464-A2 | PLANT-DERIVED AND SYNTHETIC PHENOLIC COMPOUNDS AND PLANT EXTRACTS, EFFECTIVE IN THE TREATMENT AND PREVENTION OF CHLAMYDIAL INFECTIONS | CONTROL-OX OY (FI) | 2002-02-21 | — | — | WO | claimed |
| US-6326426-B1 | POLYOLEFIN | ADVANCED ELASTOMER SYSTEMS, L.P. | 2001-12-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381101-A1 | AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | SLC5A2, SLC5A1, SLC2A2 | KAT8 4152/4885PPARA 1114/4885ALOX5 2882/4885 |
| US-20040058983-A1 | Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections | PPARG, QPCT, PGC | KAT8 1998/4885PPARA 14/4885ALOX5 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.